Andrea Melloni

Dr. Andrea Melloni

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
AKAndrea KAHLBERG
Andrea KAHLBERG
DMDaniele Mascia
Daniele Mascia
RBRaffaello Bellosta
Raffaello Bellosta
LALuca Attisani
Luca Attisani
MPMatteo Pegorer
Matteo Pegorer
RCRoberto Chiesa
Roberto Chiesa

1 June 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
LBLuca Bertoglio
Luca Bertoglio
AGAlessandro Grandi
Alessandro Grandi
AMAndrea Melloni
Andrea Melloni
AKAndrea KAHLBERG
Andrea KAHLBERG
GMGermano Melissano
Germano Melissano
RCRoberto Chiesa
Roberto Chiesa

9 April 2021 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
DMDaniele Mascia
Daniele Mascia
EREnrico Rinaldi
Enrico Rinaldi
SSSimone Salvati
Simone Salvati
AMAndrea Melloni
Andrea Melloni
AKAndrea KAHLBERG
Andrea KAHLBERG
GMGermano Melissano
Germano Melissano
Purpose: TEVAR (thoracic endovascular aortic repair) + PETTICOAT (Provisional ExTension to Induce COmplete ATtachment) technique has been selectively employed since 2005 at our institution during endovascular treatment of type B aortic dissection (TBD). The aim of this study is to evaluate the long-term (>5 years) clinical results and the evolution of aortic volume. Materials and Methods: All the patients receiving an endovascular treatment for TBD with the PETTICOAT technique were collected in a prospectively maintained database and follow-up computed tomography scan were retrospectively analyzed. Study endpoints included short- and long-term clinical success (absence of need for reintervention) and any major adverse event. The volumes of thoracic and abdominal aorta at long-term follow-up were also analyzed. Results: Twenty-eight patients received a TEVAR + PETTICOAT and were followed up (median follow-up 85 months). Primary 30-day clinical success rate was 82% with an adverse event rate of 31%; 4 type I endoleak and 1 retrograde dissection were recorded. Secondary mid-term clinical success was 96% while the long-term clinical success rate was 79%. Six cases (21%) received either an open repair or an endovascular repair for a significant distal aortic enlargement at follow-up. With regards to volumetric analysis, an increase of overall (thoracic and abdominal) aortic volume was observed in 8 cases mainly related to an increase (mean: +31%) of the abdominal volume that was observed in 11 cases. Conclusions: PETTICOAT technique does not protect from long-term significant aneurysmal degeneration that may require aortic open or endovascular reinterventions. Aortic growth occurs mainly in the bare-stented aorta and thus, life-long surveillance is advisable in these patients.

1 November 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
DMDaniele Mascia
Daniele Mascia
AKAndrea Kahlberg
Andrea Kahlberg
AMAndrea Melloni
Andrea Melloni
EREnrico Rinaldi
Enrico Rinaldi
GMGermano Melissano
Germano Melissano
RCRoberto Chiesa
Roberto Chiesa

3 March 2022 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
EREnrico Rinaldi
Enrico Rinaldi
AMAndrea Melloni
Andrea Melloni
EGEnrico Gallitto
Enrico Gallitto
AFAaron Fargion
Aaron Fargion
GIGiacomo Isernia
Giacomo Isernia
SSSpeziali Sara
Speziali Sara
Purpose: The aim of this study is to report an Italian multicenter experience analyzing the incidence and the risk factors associated with spinal cord ischemia (SCI) in a large cohort of thoracoabdominal aortic aneurysms (TAAAs) treated by fenestrated-branched endovascular aneurysm repair (F-/B-EVAR). Materials and Methods: All consecutive patients undergoing F-/B-EVAR in 4 Italian university centers between 2008 and 2019 were prospectively recorded and retrospectively analyzed. Spinal cord ischemia, 30 day/in-hospital adverse events, and mortality were assessed as early outcomes. Risk factors for SCI were determined by multivariable analysis. Results: A total of 351 patients received F-/B-EVAR for a TAAA. Twenty-eight (8.0%) patients died within 30 postoperative days or during the hospitalization. Regarding SCI, 47 patients (13.4%) developed neurological symptoms related to spinal cord impaired perfusion. Among them, 17 (4.8%) had a major permanent impairment. The multivariable analysis identified that SCI was associated with Crawford extent I to III (odds ratio [OR]: 20.90, p=0.004, 95% confidence interval [CI]=2.69–162.57), and with endovascular procedures performed for ruptured TAAA (OR: 5.74, p=0.010, 95% CI=1.53–21.57). Spinal cord ischemia was also significantly associated with a grade 3 bleeding during the visceral stage (OR: 4.34, p=0.005, 95% CI=1.55–12.16) and a grade 2 renal insufficiency at 30 days (OR: 7.45, p=0.002, 95% CI=2.12–26.18). Conclusion: The present study indicates that SCI is still an open issue after extent I to III TAAA endovascular repair, while its incidence in extent IV TAAA and pararenal/juxtarenal aneurysms is rare. Thoracoabdominal aortic aneurysms extension, urgent TAAA repair for rupture, severe bleeding, and 30 day renal insufficiency have been identified as significant risk factors for SCI. In the presence of such factors, adjunctive strategies may be considered to reduce SCI rates, while in low-risk patients invasive or potentially-risky maneuvers might not be justified.

6 August 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
DLDiletta Loschi
Diletta Loschi
AMAndrea Melloni
Andrea Melloni
AGAlessandro Grandi
Alessandro Grandi
DOMENICO BACCELLIERIDOMENICO BACCELLIERI
DOMENICO BACCELLIERI
FMFabrizio Monaco
Fabrizio Monaco
LBLuca Bertoglio
Luca Bertoglio
: OBJECTIVES: The aim of this study was to evaluate the outcomes of open and endovascular treatment of downstream thoracic or thoraco-abdominal aortic pathology in patients who underwent previous frozen elephant trunk (FET). METHODS: Data were retrieved to evaluate mortality, cardiac, pulmonary, cerebrovascular, renal and spinal cord major adverse events, early- and mid-term reintervention and survival rates. The Society for Vascular Surgery endovascular reporting standards were used. RESULTS: From 2011 to 2020, 48 patients (36 males, median age 60 years) underwent downstream aortic repair at a median of 18 months (interquartile range: 6–57) after the initial FET. Twenty-eight patients (58.3%) received open and 20 (41.7%) endovascular repair. The overall 30-day mortality was 6.3% and the initial clinical success was 88%, with no inter-group differences (P = 0.22 and 0.66 respectively). Six spinal cord deficits were recorded (13%): 3 (6.3%) were permanent. The major adverse events incidence was lower in the endovascular cohort [4 (20%) vs 14 (50%); P = 0.047], mainly due to a lower rate of grade ≥2 respiratory complications (5% vs 42.9%; P = 0.004). Assisted primary clinical success at 5 years was higher in the endovascular group (95% vs 68%, P = 0.022); freedom from reintervention at competing risk analysis (P = 0.3) and overall survival at Kaplan–Meier curves (log-rank P = 0.29) were similar. CONCLUSIONS: Downstream aortic repair after FET is feasible with both open and endovascular repair with acceptable mortality and permanent paraplegia rates. The endovascular approach has potential perioperative and mid-term advantages, but long-term durability has to be further investigated in larger cohorts.